MICHAEL D. KISHBAUCH, President and Chief Executive Officer of Achillion Pharmaceuticals, Inc., joined Achillion as President and CEO in July 2004. He has had an impressive record of launching and ...

AI revolution investing interview with Wall Street Journal’s “Best on the Street” Tore Svanberg, Managing Director at Stifel ...